January 5, 2012
Dyann House, a cancer trial participant at Phoebe Cancer Center, will continue to receive Herceptin for a full year. House, who will be part of the study for an additional 20 years, said she is glad to be a part of something that will help women all over the world.
Stories this photo appears in:
Cooperation of patients treated at the Phoebe Cancer Center gives physicians everywhere tools and information to treat the disease.